data_2eyx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2eyx _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 34.1 m120 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.831 0.348 . . . . 74.109999999999999 110.892 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 4.8 tt -82.87 -55.78 4.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 74.019999999999996 110.87 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 8.6 mp0 -39.95 -53.92 2.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 73.219999999999999 110.894 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -111.88 44.23 1.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 72.310000000000002 110.902 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -53.09 -175.72 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 73.329999999999998 112.484 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -40.46 5.39 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.663 2.242 . . . . 73.439999999999998 112.38 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 14.8 mt -58.35 123.15 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 72.349999999999994 111.12 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.492 ' O ' ' CG ' ' A' ' 239' ' ' TYR . 4.2 t80 -134.36 90.98 2.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 75.340000000000003 110.91 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.467 ' CB ' ' HA ' ' A' ' 293' ' ' LEU . . . -111.97 119.15 37.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 74.349999999999994 111.087 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 -92.01 164.56 13.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 71.430000000000007 110.917 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 0.463 ' CG2' ' HG3' ' A' ' 262' ' ' GLU . 9.1 t -109.42 152.66 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 73.219999999999999 111.127 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 24.9 pt -133.17 -2.01 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 74.010000000000005 111.133 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -129.4 141.99 50.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 65.409999999999997 110.866 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.534 ' O ' ' CD ' ' A' ' 245' ' ' LYS . 0.0 OUTLIER -103.9 101.97 11.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 72.049999999999997 110.882 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 3.7 tpp85 -115.29 131.17 57.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 71.549999999999997 110.85 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 34.0 m -87.31 138.37 32.25 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.561 0.696 . . . . 72.310000000000002 111.178 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 150.03 67.88 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.726 2.284 . . . . 73.530000000000001 112.324 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -67.49 147.04 53.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 72.439999999999998 110.914 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -62.35 -36.71 83.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 75.530000000000001 111.082 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -91.61 41.31 1.06 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 74.120000000000005 110.913 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -136.96 116.9 13.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 75.129999999999995 110.865 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp -90.94 -50.96 5.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 54.020000000000003 110.873 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' THR . . . . . 0.401 ' O ' ' CA ' ' A' ' 284' ' ' GLY . 46.9 p -84.08 29.54 0.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 74.430000000000007 111.163 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -87.92 138.68 31.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 72.430000000000007 111.092 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.473 ' HG ' ' CA ' ' A' ' 284' ' ' GLY . 15.8 mt -104.26 125.51 50.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 74.420000000000002 110.934 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -76.8 144.55 39.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 52.32 111.127 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 84.3 mt -120.97 127.55 51.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 74.25 110.921 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 260' ' ' VAL . 33.5 mt-10 -120.09 107.79 13.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 73.319999999999993 110.876 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.427 ' C ' ' O ' ' A' ' 259' ' ' GLU . 2.1 p -36.0 119.65 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 73.019999999999996 111.096 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 242' ' ' VAL . . . 82.9 62.86 1.79 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 52.43 112.477 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.463 ' HG3' ' CG2' ' A' ' 242' ' ' VAL . 6.7 pt-20 -150.22 157.64 43.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.856 0.36 . . . . 74.299999999999997 110.89 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.36 122.14 36.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 73.230000000000004 110.912 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.506 ' CG2' ' HA ' ' A' ' 279' ' ' CYS . 0.1 OUTLIER -131.64 137.46 55.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 65.340000000000003 111.145 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.568 ' C ' ' O ' ' A' ' 278' ' ' GLU . 0.2 OUTLIER -127.84 86.07 2.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 75.019999999999996 110.893 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.546 HG12 ' CE2' ' A' ' 286' ' ' PHE . 8.2 m -51.25 -163.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 62.32 111.115 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' THR . . . . . 0.609 ' N ' ' HA3' ' A' ' 277' ' ' GLY . 80.5 p -134.2 -39.02 0.85 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 75.200000000000003 111.152 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -139.18 114.16 9.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 74.329999999999998 110.913 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ILE . . . . . 0.54 HG22 ' CD1' ' A' ' 275' ' ' TRP . 68.8 mt -82.34 119.49 31.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 63.549999999999997 111.118 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -83.38 167.71 17.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 72.510000000000005 110.913 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 16.1 m -93.24 3.86 8.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 72.549999999999997 111.134 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 9.4 t -105.43 15.98 26.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 65.230000000000004 110.891 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 77.0 16.35 80.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.776 -0.726 . . . . 74.319999999999993 112.44 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -119.2 112.68 19.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.767 0.317 . . . . 75.120000000000005 110.927 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.727 ' CH2' ' CE1' ' A' ' 288' ' ' PHE . 23.9 m0 -101.17 124.96 47.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.201 -0.454 . . . . 75.450000000000003 110.916 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -114.73 134.27 55.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 73.329999999999998 110.936 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.609 ' HA3' ' N ' ' A' ' 267' ' ' THR . . . 162.44 -119.89 0.91 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.742 . . . . 74.450000000000003 112.464 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.568 ' O ' ' C ' ' A' ' 265' ' ' LYS . 3.9 tt0 -103.73 123.59 47.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.924 0.392 . . . . 72.510000000000005 110.878 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' CYS . . . . . 0.506 ' HA ' ' CG2' ' A' ' 264' ' ' VAL . 25.7 t -135.16 111.94 10.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 61.109999999999999 110.895 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.414 ' HB2' ' CD ' ' A' ' 262' ' ' GLU . 61.1 t30 50.3 39.76 20.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 74.340000000000003 110.895 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 77.34 22.46 70.48 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.767 -0.73 . . . . 74.450000000000003 112.482 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . 0.446 ' CB ' ' CD2' ' A' ' 256' ' ' LEU . 34.6 mttm -125.06 162.47 24.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.79 0.329 . . . . 74.040000000000006 110.883 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . 0.434 ' HD3' ' N ' ' A' ' 283' ' ' ARG . 0.0 OUTLIER -122.55 136.07 54.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 72.439999999999998 110.921 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . 0.473 ' CA ' ' HG ' ' A' ' 256' ' ' LEU . . . 153.52 -153.83 25.1 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.752 -0.737 . . . . 75.299999999999997 112.46 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -123.06 135.91 54.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.882 0.372 . . . . 73.400000000000006 110.856 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.546 ' CE2' HG12 ' A' ' 266' ' ' VAL . 3.7 p90 -139.55 148.28 55.55 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.682 0.753 . . . . 74.209999999999994 110.867 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 97.73 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.7 2.266 . . . . 74.430000000000007 112.397 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.727 ' CE1' ' CH2' ' A' ' 275' ' ' TRP . 3.5 t80 -57.11 -12.04 1.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 74.129999999999995 110.889 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 67.3 p -69.83 0.84 5.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 75.209999999999994 111.173 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -130.7 26.17 5.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 75.439999999999998 110.865 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 2.3 m -144.14 161.25 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 73.340000000000003 111.136 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -115.35 141.81 47.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 75.140000000000001 110.88 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . 0.467 ' HA ' ' CB ' ' A' ' 240' ' ' ALA . 1.3 pt? -110.57 145.69 37.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 71.209999999999994 110.901 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 5.5 mp -144.28 153.97 42.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 74.120000000000005 110.916 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.46 ' O ' ' CG ' ' A' ' 296' ' ' GLN . 30.6 p-10 -110.4 27.59 9.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 74.329999999999998 110.852 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.46 ' CG ' ' O ' ' A' ' 295' ' ' ASP . 27.2 pt20 45.28 50.27 9.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 75.340000000000003 110.91 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -143.24 108.63 5.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 74.409999999999997 110.964 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 30.2 t30 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 74.310000000000002 110.852 -179.929 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 34.1 m120 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.831 0.348 . . . . 74.109999999999999 110.892 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 4.8 tt -82.87 -55.78 4.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 73.450000000000003 110.87 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 8.6 mp0 -39.95 -53.92 2.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 41.439999999999998 110.894 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -111.88 44.23 1.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 72.310000000000002 110.902 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -53.09 -175.72 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 52.219999999999999 112.484 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -40.46 5.39 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.663 2.242 . . . . 73.439999999999998 112.38 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 14.8 mt -58.35 123.15 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 52.109999999999999 111.12 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.492 ' O ' ' CG ' ' A' ' 239' ' ' TYR . 4.2 t80 -134.36 90.98 2.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 75.340000000000003 110.91 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.498 ' O ' HG13 ' A' ' 264' ' ' VAL . . . -111.97 119.15 37.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 64.519999999999996 111.087 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 -92.01 164.56 13.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 71.430000000000007 110.917 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.544 HG23 ' HG3' ' A' ' 262' ' ' GLU . 9.1 t -109.42 152.66 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 61.409999999999997 111.127 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.591 ' O ' HG23 ' A' ' 260' ' ' VAL . 24.9 pt -133.17 -2.01 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 74.010000000000005 111.133 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.518 ' H ' HG12 ' A' ' 242' ' ' VAL . 3.0 tp-100 -129.4 141.99 50.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 65.409999999999997 110.866 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.819 ' HB3' HG12 ' A' ' 260' ' ' VAL . 0.0 OUTLIER -103.9 101.97 11.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 72.049999999999997 110.882 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 3.7 tpp85 -115.29 131.17 57.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 71.549999999999997 110.85 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 34.0 m -87.31 138.37 32.25 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.561 0.696 . . . . 72.310000000000002 111.178 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 150.03 67.88 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.726 2.284 . . . . 73.530000000000001 112.324 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -67.49 147.04 53.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 72.439999999999998 110.914 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -62.35 -36.71 83.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 73.120000000000005 111.082 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -91.61 41.31 1.06 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 72.219999999999999 110.913 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.886 ' CG ' ' HB2' ' A' ' 255' ' ' ALA . 10.8 t0 -136.96 116.9 13.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 72.099999999999994 110.865 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp -90.94 -50.96 5.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 52.130000000000003 110.873 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.401 ' O ' ' CA ' ' A' ' 284' ' ' GLY . 46.9 p -84.08 29.54 0.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 72.299999999999997 111.163 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.886 ' HB2' ' CG ' ' A' ' 252' ' ' ASP . . . -87.92 138.68 31.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 44.509999999999998 111.092 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.805 HD22 ' HB3' ' A' ' 279' ' ' CYS . 15.8 mt -104.26 125.51 50.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 53.520000000000003 110.934 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -76.8 144.55 39.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 44.409999999999997 111.127 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 84.3 mt -120.97 127.55 51.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 51.420000000000002 110.921 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 260' ' ' VAL . 33.5 mt-10 -120.09 107.79 13.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 73.319999999999993 110.876 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.819 HG12 ' HB3' ' A' ' 245' ' ' LYS . 2.1 p -36.0 119.65 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 73.019999999999996 111.096 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 82.9 62.86 1.79 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 52.43 112.477 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.544 ' HG3' HG23 ' A' ' 242' ' ' VAL . 6.7 pt-20 -150.22 157.64 43.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.856 0.36 . . . . 72.340000000000003 110.89 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.552 HD23 ' N ' ' A' ' 264' ' ' VAL . 0.5 OUTLIER -94.36 122.14 36.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 71.329999999999998 110.912 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.813 HG23 ' HA ' ' A' ' 279' ' ' CYS . 0.1 OUTLIER -131.64 137.46 55.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 65.340000000000003 111.145 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.568 ' C ' ' O ' ' A' ' 278' ' ' GLU . 0.2 OUTLIER -127.84 86.07 2.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 75.019999999999996 110.893 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.712 HG12 ' CE2' ' A' ' 286' ' ' PHE . 8.2 m -51.25 -163.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 60.399999999999999 111.115 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' THR . . . . . 0.693 HG23 ' CA ' ' A' ' 277' ' ' GLY . 80.5 p -134.2 -39.02 0.85 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 51.119999999999997 111.152 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -139.18 114.16 9.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 74.329999999999998 110.913 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ILE . . . . . 0.903 HG23 ' NE1' ' A' ' 275' ' ' TRP . 68.8 mt -82.34 119.49 31.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 62.32 111.118 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -83.38 167.71 17.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 71.420000000000002 110.913 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 16.1 m -93.24 3.86 8.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 72.549999999999997 111.134 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 9.4 t -105.43 15.98 26.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 64.140000000000001 110.891 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 77.0 16.35 80.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.776 -0.726 . . . . 74.319999999999993 112.44 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -119.2 112.68 19.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.767 0.317 . . . . 72.109999999999999 110.927 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.903 ' NE1' HG23 ' A' ' 269' ' ' ILE . 23.9 m0 -101.17 124.96 47.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.201 -0.454 . . . . 73.150000000000006 110.916 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -114.73 134.27 55.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 54.240000000000002 110.936 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.693 ' CA ' HG23 ' A' ' 267' ' ' THR . . . 162.44 -119.89 0.91 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.742 . . . . 74.450000000000003 112.464 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.568 ' O ' ' C ' ' A' ' 265' ' ' LYS . 3.9 tt0 -103.73 123.59 47.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.924 0.392 . . . . 71.129999999999995 110.878 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' CYS . . . . . 0.813 ' HA ' HG23 ' A' ' 264' ' ' VAL . 25.7 t -135.16 111.94 10.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 61.109999999999999 110.895 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.421 ' HB2' ' CD ' ' A' ' 262' ' ' GLU . 61.1 t30 50.3 39.76 20.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 74.340000000000003 110.895 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 77.34 22.46 70.48 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.767 -0.73 . . . . 21.41 112.482 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' LYS . . . . . 0.684 ' C ' HD21 ' A' ' 256' ' ' LEU . 34.6 mttm -125.06 162.47 24.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.79 0.329 . . . . 73.420000000000002 110.883 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.546 ' N ' HD21 ' A' ' 256' ' ' LEU . 0.0 OUTLIER -122.55 136.07 54.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 72.439999999999998 110.921 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 284' ' ' GLY . . . . . 0.475 ' CA ' ' HG ' ' A' ' 256' ' ' LEU . . . 153.52 -153.83 25.1 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.752 -0.737 . . . . 75.299999999999997 112.46 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -123.06 135.91 54.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.882 0.372 . . . . 73.400000000000006 110.856 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.712 ' CE2' HG12 ' A' ' 266' ' ' VAL . 3.7 p90 -139.55 148.28 55.55 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.682 0.753 . . . . 74.209999999999994 110.867 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 97.73 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.7 2.266 . . . . 74.430000000000007 112.397 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.727 ' CE1' ' CH2' ' A' ' 275' ' ' TRP . 3.5 t80 -57.11 -12.04 1.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 72.129999999999995 110.889 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 67.3 p -69.83 0.84 5.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 64.540000000000006 111.173 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -130.7 26.17 5.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 75.439999999999998 110.865 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.473 HG12 HG13 ' A' ' 242' ' ' VAL . 2.3 m -144.14 161.25 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 72.319999999999993 111.136 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -115.35 141.81 47.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 75.140000000000001 110.88 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' LEU . . . . . 0.473 ' HA ' ' CB ' ' A' ' 240' ' ' ALA . 1.3 pt? -110.57 145.69 37.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 64.099999999999994 110.901 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.435 HD12 ' C ' ' A' ' 293' ' ' LEU . 5.5 mp -144.28 153.97 42.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 62.409999999999997 110.916 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.46 ' O ' ' CG ' ' A' ' 296' ' ' GLN . 30.6 p-10 -110.4 27.59 9.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 74.329999999999998 110.852 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.46 ' CG ' ' O ' ' A' ' 295' ' ' ASP . 27.2 pt20 45.28 50.27 9.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 75.340000000000003 110.91 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -143.24 108.63 5.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 72.340000000000003 110.964 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 30.2 t30 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 44.219999999999999 110.852 -179.929 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 34.1 m120 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.831 0.348 . . . . 74.11 110.892 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 4.8 tt -82.87 -55.78 4.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 73.45 110.87 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 8.6 mp0 -39.95 -53.92 2.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 41.44 110.894 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -111.88 44.23 1.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 72.31 110.902 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -53.09 -175.72 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 52.22 112.484 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -40.46 5.39 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.663 2.242 . . . . 73.44 112.38 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 14.8 mt -58.35 123.15 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 52.11 111.12 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.492 ' CG ' ' O ' ' A' ' 239' ' ' TYR . 4.2 t80 -134.36 90.98 2.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 75.34 110.91 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.498 ' O ' HG13 ' A' ' 264' ' ' VAL . . . -111.97 119.15 37.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 64.52 111.087 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 -92.01 164.56 13.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 71.43 110.917 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.544 HG23 ' HG3' ' A' ' 262' ' ' GLU . 9.1 t -109.42 152.66 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 61.41 111.127 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.591 ' O ' HG23 ' A' ' 260' ' ' VAL . 24.9 pt -133.17 -2.01 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 74.01 111.133 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.518 ' H ' HG12 ' A' ' 242' ' ' VAL . 3.0 tp-100 -129.4 141.99 50.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 65.41 110.866 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.819 ' HB3' HG12 ' A' ' 260' ' ' VAL . 0.0 OUTLIER -103.9 101.97 11.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 72.05 110.882 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 3.7 tpp85 -115.29 131.17 57.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 71.55 110.85 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 34.0 m -87.31 138.37 32.25 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.561 0.696 . . . . 72.31 111.178 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 150.03 67.88 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.726 2.284 . . . . 73.53 112.324 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -67.49 147.04 53.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 72.44 110.914 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -62.35 -36.71 83.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 73.12 111.082 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -91.61 41.31 1.06 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 72.22 110.913 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.886 ' CG ' ' HB2' ' A' ' 255' ' ' ALA . 10.8 t0 -136.96 116.9 13.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 72.1 110.865 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp -90.94 -50.96 5.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 52.13 110.873 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.401 ' O ' ' CA ' ' A' ' 284' ' ' GLY . 46.9 p -84.08 29.54 0.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 72.3 111.163 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.886 ' HB2' ' CG ' ' A' ' 252' ' ' ASP . . . -87.92 138.68 31.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 44.51 111.092 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.805 HD22 ' HB3' ' A' ' 279' ' ' CYS . 15.8 mt -104.26 125.51 50.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 53.52 110.934 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -76.8 144.55 39.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 44.41 111.127 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 84.3 mt -120.97 127.55 51.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 51.42 110.921 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 260' ' ' VAL . 33.5 mt-10 -120.09 107.79 13.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 73.32 110.876 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.819 HG12 ' HB3' ' A' ' 245' ' ' LYS . 2.1 p -36.0 119.65 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 73.02 111.096 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 82.9 62.86 1.79 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 52.43 112.477 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.544 ' HG3' HG23 ' A' ' 242' ' ' VAL . 6.7 pt-20 -150.22 157.64 43.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.856 0.36 . . . . 72.34 110.89 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.552 HD23 ' N ' ' A' ' 264' ' ' VAL . 0.5 OUTLIER -94.36 122.14 36.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 71.33 110.912 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.813 HG23 ' HA ' ' A' ' 279' ' ' CYS . 0.1 OUTLIER -131.64 137.46 55.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 65.34 111.145 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.568 ' C ' ' O ' ' A' ' 278' ' ' GLU . 0.2 OUTLIER -127.84 86.07 2.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 75.02 110.893 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.712 HG12 ' CE2' ' A' ' 286' ' ' PHE . 8.2 m -51.25 -163.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 60.4 111.115 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . 0.693 HG23 ' CA ' ' A' ' 277' ' ' GLY . 80.5 p -134.2 -39.02 0.85 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.162 -0.472 . . . . 51.12 111.152 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -139.18 114.16 9.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 74.33 110.913 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ILE . . . . . 0.903 HG23 ' NE1' ' A' ' 275' ' ' TRP . 68.8 mt -82.34 119.49 31.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 62.32 111.118 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -83.38 167.71 17.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 71.42 110.913 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 16.1 m -93.24 3.86 8.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 72.55 111.134 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 9.4 t -105.43 15.98 26.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 64.14 110.891 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 77.0 16.35 80.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.776 -0.726 . . . . 74.32 112.44 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -119.2 112.68 19.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.767 0.317 . . . . 72.11 110.927 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.903 ' NE1' HG23 ' A' ' 269' ' ' ILE . 23.9 m0 -101.17 124.96 47.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.201 -0.454 . . . . 73.15 110.916 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -114.73 134.27 55.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 54.24 110.936 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.693 ' CA ' HG23 ' A' ' 267' ' ' THR . . . 162.44 -119.89 0.91 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.742 . . . . 74.45 112.464 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.568 ' O ' ' C ' ' A' ' 265' ' ' LYS . 3.9 tt0 -103.73 123.59 47.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.924 0.392 . . . . 71.13 110.878 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' CYS . . . . . 0.813 ' HA ' HG23 ' A' ' 264' ' ' VAL . 25.7 t -135.16 111.94 10.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 61.11 110.895 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.421 ' HB2' ' CD ' ' A' ' 262' ' ' GLU . 61.1 t30 50.3 39.76 20.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 74.34 110.895 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 77.34 22.46 70.48 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.767 -0.73 . . . . 21.41 112.482 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . 0.684 ' C ' HD21 ' A' ' 256' ' ' LEU . 34.6 mttm -125.06 162.47 24.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.79 0.329 . . . . 73.42 110.883 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.546 ' N ' HD21 ' A' ' 256' ' ' LEU . 0.0 OUTLIER -122.55 136.07 54.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 72.44 110.921 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . 0.475 ' CA ' ' HG ' ' A' ' 256' ' ' LEU . . . 153.52 -153.83 25.1 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.752 -0.737 . . . . 75.3 112.46 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -123.06 135.91 54.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.882 0.372 . . . . 73.4 110.856 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.712 ' CE2' HG12 ' A' ' 266' ' ' VAL . 3.7 p90 -139.55 148.28 55.55 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.682 0.753 . . . . 74.21 110.867 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 97.73 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.7 2.266 . . . . 74.43 112.397 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.727 ' CE1' ' CH2' ' A' ' 275' ' ' TRP . 3.5 t80 -57.11 -12.04 1.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 72.13 110.889 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 67.3 p -69.83 0.84 5.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 64.54 111.173 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -130.7 26.17 5.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 75.44 110.865 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.473 HG12 HG13 ' A' ' 242' ' ' VAL . 2.3 m -144.14 161.25 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 72.32 111.136 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -115.35 141.81 47.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 75.14 110.88 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . 0.473 ' HA ' ' CB ' ' A' ' 240' ' ' ALA . 1.3 pt? -110.57 145.69 37.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 64.1 110.901 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.435 HD12 ' C ' ' A' ' 293' ' ' LEU . 5.5 mp -144.28 153.97 42.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 62.41 110.916 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.46 ' O ' ' CG ' ' A' ' 296' ' ' GLN . 30.6 p-10 -110.4 27.59 9.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 74.33 110.852 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.46 ' CG ' ' O ' ' A' ' 295' ' ' ASP . 27.2 pt20 45.28 50.27 9.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 75.34 110.91 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -143.24 108.63 5.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 72.34 110.964 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 30.2 t30 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 44.22 110.852 -179.929 . . . . . . . . 0 0 . 1 stop_ save_